APIs, Ingredients & Formulation

Thursday 20 May

20 MAY 2021

APIs, Ingredients & Formulation

LIVE PANEL - 15:00-16:00 CET

The API Landscape - Reshoring, Trading & Sourcing Dynamics

API manufacturing has always been about innovating to cater for shifting demand patterns, but the recent coronavirus pandemic has raised further questions about manufacturing hubs and consistency of supply. Are we on the brink of a major shift in API production?

Discussion points

The complexity of globally interconnected pharmaceutical supply chains
Market pressures to modernize API supply chains through digitization
The role of trading in the API supply chain
Offshore vs Onshore Manufacturing
Could reshoring represent an opportunity for boosting innovation and new manufacturing technologies to compete effectively and take a greener approach?

Moderator: Aurelio Arias - Engagement Manager – IQVIA
Brandon Boyd, Director of Life Sciences Strategy, Clarivate
Stefan Schmidinger, Partner, Markets & Business Development, Kemiex AG
Matt Hicks, Chief Operating Officer & Counsel, Federal Equipment Company

PRESENTATION - ON DEMAND

Sponsored by Clarivate Analytics

Overcoming Drug Development Challenges with Nanotechnology

This session will focus on the application of nanotechnology to drug development, and explore areas of opportunity where current and emerging nanotechnologies could enable entirely novel classes of therapeutics.

Discussion points

Gain perspective on the current status and the future growth of the field.
What are the most promising nanotechnology platforms to overcome drug development challenges?
Specific applications of emerging interest in nanotechnology-based drug development systems
The Nanotechnology role in Vaccine Development
The potential impact of Nanotechnology in the development of Personalized Medicine

20 MAY 2021

PRESENTATION - ON DEMAND

Value Added Excipients to Unlock the Potential of APIs

The humble excipient can play an important role in improving drug formulation, particularly in terms of solubility and stability. This session will explore how to add value to your drug development.

Discussion points

The Vital Role Excipients play in producing new drugs and consumer products.
An overview of Excipient Quality and Impact on Formulation
Excipients Added to Solid Oral Dosage Forms to Improve Drug Solubility and/or Dissolution
Latest Developments, demands & trends in the Excipients Market
Examples of some Solutions, technologies, and regulatory changes happening on a global scale

Chris Moreton, VP, Pharmaceutical Sciences, FinnBrit Consulting
Iain Moore, President EXCiPACT asbl

20 MAY 2021

CPHI WEBINAR SERIES - REPURPOSED CONTENT

API Manufacturing Trends

The global market for the outlook and manufacture of APIs is shifting as more complex or potent ingredients evolve which present specific handling and manufacturing challenges.

What are the latest technological approaches for these products, and how can quality, safety and cost be managed and improved upon?

A key impact of the COVID-19 pandemic has been to question the reliance and dependence on Asia as the global leader of API manufacturing. Do we expect to see specific regions implement reshoring of manufacturing efforts? How will global supply chains be impacted?

Market Outlook for APIs
Can we expect a reshoring of API manufacturing? Will hubs shift from Asia?
Continuous API manufacturing –for cost, quality and safety benefits
Manufacturing considerations for complex formulations and high potency APIs, what are the latest approaches?

Molly Bowman, Editorial Director, Clarivate Analytics
Stuart E. Needleman, Chief Commercial Officer, Piramal Pharma Solutions
Gianluca Franguelli, Vice President Global Drug Substance Development, Recipharm

PRESENTATION - ON DEMAND

Formulating Plant-Based Ingredients for Cosmeceuticals

The Cosmeceuticals market is projected to grow 8.9% in the period 2020-2026, driven primarily by conscious consumers who are looking for increased potency in products which offer better efficacy than standard OTC solutions. Beyond this, consumers are also increasingly concerned about potentially harmful chemicals in cosmetics, leaning instead towards natural and plant-based solutions. This session will address cosmeceutical market dynamics and identify opportunities for growth.

Discussion points:

• What are the key growth drivers for the Cosmeceuticals market?
• Formulating plant-based ingredients - challenges and opportunities
• Responding to the demand for plant-based ingredients
• Regulatory considerations for natural ingredients and cosmetics
• Developing sustainable solutions to differentiate your business for the conscious consumer

20 MAY 2021

Sponsored by Nanoform

Unlocking the Power and Versatility of Plant-Based Softgels

While plant-based diets continue to grow in popularity, the desire to live and act more sustainably and healthfully is on the rise. With our Vegetarian Softgel Technology, Versagel™, companies can now offer their patients and consumers Non-GMO, plant-based softgel products as an optimal solution for their latest demands without losing the versatility and benefits of regular softgel capsules. Changing to a plant-based alternative should not affect overall product performance and quality. Versagel™ offers not only great appearance, but an overall competitive edge, the cornerstone for your next big project. Join us!

Carolina Quintero, Director of New Pharmaceutical Technologies, Procaps

PRESENTATION - ON DEMAND

20 MAY 2021

Sponsored by Procaps